flowcomp™ release buffer Search Results


86
Thermo Fisher flowcomp release buffer
Flowcomp Release Buffer, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/flowcomp release buffer/product/Thermo Fisher
Average 86 stars, based on 1 article reviews
flowcomp release buffer - by Bioz Stars, 2026-03
86/100 stars
  Buy from Supplier

90
Thermo Fisher flowcomp release buffer flowcomp flexi kit 11061d
Characterization of bead–antibody binding. (A) Magnetic bead fluorescence intensity curves generated by varying densities of a fluorescently labeled anti-EpCAM antibody on beads. A 50% maximal binding capacity for each bead type was then identified ( Table S2 ). Dots represent the average of three technical replicates consisting of 100 beads each (300 beads total); error bars represent the standard deviation of the analyzed population. (B) Impact of the bead’s antibody density on target capture. The 50% maximal antibody binding density for M-280s and FlowComps is denoted by their respective vertical dashed line. Points represent the average of three technical replicates; error bars represent the standard deviation; * denotes p < 0.05, which in this case applies to both M-280 and <t>FlowComp.</t>
Flowcomp Release Buffer Flowcomp Flexi Kit 11061d, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/flowcomp release buffer flowcomp flexi kit 11061d/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
flowcomp release buffer flowcomp flexi kit 11061d - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
GenVault Corporation genvault release buffer
Characterization of bead–antibody binding. (A) Magnetic bead fluorescence intensity curves generated by varying densities of a fluorescently labeled anti-EpCAM antibody on beads. A 50% maximal binding capacity for each bead type was then identified ( Table S2 ). Dots represent the average of three technical replicates consisting of 100 beads each (300 beads total); error bars represent the standard deviation of the analyzed population. (B) Impact of the bead’s antibody density on target capture. The 50% maximal antibody binding density for M-280s and FlowComps is denoted by their respective vertical dashed line. Points represent the average of three technical replicates; error bars represent the standard deviation; * denotes p < 0.05, which in this case applies to both M-280 and <t>FlowComp.</t>
Genvault Release Buffer, supplied by GenVault Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/genvault release buffer/product/GenVault Corporation
Average 90 stars, based on 1 article reviews
genvault release buffer - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Siepmann GmbH protease type xiv
Characterization of bead–antibody binding. (A) Magnetic bead fluorescence intensity curves generated by varying densities of a fluorescently labeled anti-EpCAM antibody on beads. A 50% maximal binding capacity for each bead type was then identified ( Table S2 ). Dots represent the average of three technical replicates consisting of 100 beads each (300 beads total); error bars represent the standard deviation of the analyzed population. (B) Impact of the bead’s antibody density on target capture. The 50% maximal antibody binding density for M-280s and FlowComps is denoted by their respective vertical dashed line. Points represent the average of three technical replicates; error bars represent the standard deviation; * denotes p < 0.05, which in this case applies to both M-280 and <t>FlowComp.</t>
Protease Type Xiv, supplied by Siepmann GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/protease type xiv/product/Siepmann GmbH
Average 90 stars, based on 1 article reviews
protease type xiv - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
BGI Shenzhen cdna release mix
Characterization of bead–antibody binding. (A) Magnetic bead fluorescence intensity curves generated by varying densities of a fluorescently labeled anti-EpCAM antibody on beads. A 50% maximal binding capacity for each bead type was then identified ( Table S2 ). Dots represent the average of three technical replicates consisting of 100 beads each (300 beads total); error bars represent the standard deviation of the analyzed population. (B) Impact of the bead’s antibody density on target capture. The 50% maximal antibody binding density for M-280s and FlowComps is denoted by their respective vertical dashed line. Points represent the average of three technical replicates; error bars represent the standard deviation; * denotes p < 0.05, which in this case applies to both M-280 and <t>FlowComp.</t>
Cdna Release Mix, supplied by BGI Shenzhen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cdna release mix/product/BGI Shenzhen
Average 90 stars, based on 1 article reviews
cdna release mix - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Thermo Fisher catch release ip wash buffer
Characterization of bead–antibody binding. (A) Magnetic bead fluorescence intensity curves generated by varying densities of a fluorescently labeled anti-EpCAM antibody on beads. A 50% maximal binding capacity for each bead type was then identified ( Table S2 ). Dots represent the average of three technical replicates consisting of 100 beads each (300 beads total); error bars represent the standard deviation of the analyzed population. (B) Impact of the bead’s antibody density on target capture. The 50% maximal antibody binding density for M-280s and FlowComps is denoted by their respective vertical dashed line. Points represent the average of three technical replicates; error bars represent the standard deviation; * denotes p < 0.05, which in this case applies to both M-280 and <t>FlowComp.</t>
Catch Release Ip Wash Buffer, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/catch release ip wash buffer/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
catch release ip wash buffer - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Immunotec inc histamine-release buffer
Characterization of bead–antibody binding. (A) Magnetic bead fluorescence intensity curves generated by varying densities of a fluorescently labeled anti-EpCAM antibody on beads. A 50% maximal binding capacity for each bead type was then identified ( Table S2 ). Dots represent the average of three technical replicates consisting of 100 beads each (300 beads total); error bars represent the standard deviation of the analyzed population. (B) Impact of the bead’s antibody density on target capture. The 50% maximal antibody binding density for M-280s and FlowComps is denoted by their respective vertical dashed line. Points represent the average of three technical replicates; error bars represent the standard deviation; * denotes p < 0.05, which in this case applies to both M-280 and <t>FlowComp.</t>
Histamine Release Buffer, supplied by Immunotec inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/histamine-release buffer/product/Immunotec inc
Average 90 stars, based on 1 article reviews
histamine-release buffer - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Promega release buffer (1x rnaseone buffer (promega), 0.01% tween20
Characterization of bead–antibody binding. (A) Magnetic bead fluorescence intensity curves generated by varying densities of a fluorescently labeled anti-EpCAM antibody on beads. A 50% maximal binding capacity for each bead type was then identified ( Table S2 ). Dots represent the average of three technical replicates consisting of 100 beads each (300 beads total); error bars represent the standard deviation of the analyzed population. (B) Impact of the bead’s antibody density on target capture. The 50% maximal antibody binding density for M-280s and FlowComps is denoted by their respective vertical dashed line. Points represent the average of three technical replicates; error bars represent the standard deviation; * denotes p < 0.05, which in this case applies to both M-280 and <t>FlowComp.</t>
Release Buffer (1x Rnaseone Buffer (Promega), 0.01% Tween20, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/release buffer (1x rnaseone buffer (promega), 0.01% tween20/product/Promega
Average 90 stars, based on 1 article reviews
release buffer (1x rnaseone buffer (promega), 0.01% tween20 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

96
Qiagen lysis release buffer al
Characterization of bead–antibody binding. (A) Magnetic bead fluorescence intensity curves generated by varying densities of a fluorescently labeled anti-EpCAM antibody on beads. A 50% maximal binding capacity for each bead type was then identified ( Table S2 ). Dots represent the average of three technical replicates consisting of 100 beads each (300 beads total); error bars represent the standard deviation of the analyzed population. (B) Impact of the bead’s antibody density on target capture. The 50% maximal antibody binding density for M-280s and FlowComps is denoted by their respective vertical dashed line. Points represent the average of three technical replicates; error bars represent the standard deviation; * denotes p < 0.05, which in this case applies to both M-280 and <t>FlowComp.</t>
Lysis Release Buffer Al, supplied by Qiagen, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lysis release buffer al/product/Qiagen
Average 96 stars, based on 1 article reviews
lysis release buffer al - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

90
TwistDx Inc twistdx rehydration buffer
Characterization of bead–antibody binding. (A) Magnetic bead fluorescence intensity curves generated by varying densities of a fluorescently labeled anti-EpCAM antibody on beads. A 50% maximal binding capacity for each bead type was then identified ( Table S2 ). Dots represent the average of three technical replicates consisting of 100 beads each (300 beads total); error bars represent the standard deviation of the analyzed population. (B) Impact of the bead’s antibody density on target capture. The 50% maximal antibody binding density for M-280s and FlowComps is denoted by their respective vertical dashed line. Points represent the average of three technical replicates; error bars represent the standard deviation; * denotes p < 0.05, which in this case applies to both M-280 and <t>FlowComp.</t>
Twistdx Rehydration Buffer, supplied by TwistDx Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/twistdx rehydration buffer/product/TwistDx Inc
Average 90 stars, based on 1 article reviews
twistdx rehydration buffer - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc stemcell beads
Characterization of bead–antibody binding. (A) Magnetic bead fluorescence intensity curves generated by varying densities of a fluorescently labeled anti-EpCAM antibody on beads. A 50% maximal binding capacity for each bead type was then identified ( Table S2 ). Dots represent the average of three technical replicates consisting of 100 beads each (300 beads total); error bars represent the standard deviation of the analyzed population. (B) Impact of the bead’s antibody density on target capture. The 50% maximal antibody binding density for M-280s and FlowComps is denoted by their respective vertical dashed line. Points represent the average of three technical replicates; error bars represent the standard deviation; * denotes p < 0.05, which in this case applies to both M-280 and <t>FlowComp.</t>
Stemcell Beads, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/stemcell beads/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
stemcell beads - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Characterization of bead–antibody binding. (A) Magnetic bead fluorescence intensity curves generated by varying densities of a fluorescently labeled anti-EpCAM antibody on beads. A 50% maximal binding capacity for each bead type was then identified ( Table S2 ). Dots represent the average of three technical replicates consisting of 100 beads each (300 beads total); error bars represent the standard deviation of the analyzed population. (B) Impact of the bead’s antibody density on target capture. The 50% maximal antibody binding density for M-280s and FlowComps is denoted by their respective vertical dashed line. Points represent the average of three technical replicates; error bars represent the standard deviation; * denotes p < 0.05, which in this case applies to both M-280 and FlowComp.

Journal: ACS Omega

Article Title: Integration of Magnetic Bead-Based Cell Selection into Complex Isolations

doi: 10.1021/acsomega.7b01427

Figure Lengend Snippet: Characterization of bead–antibody binding. (A) Magnetic bead fluorescence intensity curves generated by varying densities of a fluorescently labeled anti-EpCAM antibody on beads. A 50% maximal binding capacity for each bead type was then identified ( Table S2 ). Dots represent the average of three technical replicates consisting of 100 beads each (300 beads total); error bars represent the standard deviation of the analyzed population. (B) Impact of the bead’s antibody density on target capture. The 50% maximal antibody binding density for M-280s and FlowComps is denoted by their respective vertical dashed line. Points represent the average of three technical replicates; error bars represent the standard deviation; * denotes p < 0.05, which in this case applies to both M-280 and FlowComp.

Article Snippet: For experiments involving release, a similar experimental design was followed, except that once washed, the beads and bound cells were dropped into a release well containing either FlowComp Release Buffer (FlowComp Flexi Kit 11061D, Thermo Fisher) or CELLection release buffer (CELLection Biotin Binder Kit 11533D, Thermo Fisher) prepared according to the manufacturer’s instructions (release volume of 110 μL).

Techniques: Binding Assay, Fluorescence, Generated, Labeling, Standard Deviation

Characterization of cell capture. (A) Capture of EpCAM-expressing cell lines (Du145 = low, 22Rv1 = medium, LNCaP = high) by each bead type. Beads are abbreviated as follows: SM = Sera-Mag, FC = FlowComp, CELL = CELLection. (B) Nonspecific capture of PBMCs by each bead type across varying PBMC inputs. (C) Direct vs indirect capture of Du145s from a PBMC background. (D) Resultant purity of the captured target cells from direct and indirect capture of Du145s. In all plots, the bars represent the technical replicate average ( n = 3) with error bars representing the standard deviation.

Journal: ACS Omega

Article Title: Integration of Magnetic Bead-Based Cell Selection into Complex Isolations

doi: 10.1021/acsomega.7b01427

Figure Lengend Snippet: Characterization of cell capture. (A) Capture of EpCAM-expressing cell lines (Du145 = low, 22Rv1 = medium, LNCaP = high) by each bead type. Beads are abbreviated as follows: SM = Sera-Mag, FC = FlowComp, CELL = CELLection. (B) Nonspecific capture of PBMCs by each bead type across varying PBMC inputs. (C) Direct vs indirect capture of Du145s from a PBMC background. (D) Resultant purity of the captured target cells from direct and indirect capture of Du145s. In all plots, the bars represent the technical replicate average ( n = 3) with error bars representing the standard deviation.

Article Snippet: For experiments involving release, a similar experimental design was followed, except that once washed, the beads and bound cells were dropped into a release well containing either FlowComp Release Buffer (FlowComp Flexi Kit 11061D, Thermo Fisher) or CELLection release buffer (CELLection Biotin Binder Kit 11533D, Thermo Fisher) prepared according to the manufacturer’s instructions (release volume of 110 μL).

Techniques: Expressing, Standard Deviation

Characterization of the release from FlowComp and CELLection beads. (A,B) Release of a fluorescently labeled anti-EpCAM antibody from (A) FlowComp and (B) CELLection beads. Beads were labeled with low, medium, and high levels of antibody and released for the specified time intervals. (A,B) Dots represent the average of three technical replicates with each technical replicate representing the average of 100 beads (total of 300 beads); error bars represent the standard deviation of the technical replicates. (C) Release of 22Rv1s from FlowComp and CELLection beads across time. (D) Capture efficiency of both FlowComp and CELLection beads when used to capture Du145, 22Rv1, and LNCaP cells. (E) Release efficiency of the three cell lines following bead-based capture. (F) Effective capture following the release of the cells. Gray bars represent the population of cells lost during the release process because of the inefficient release. In each plot, bars represent an average of n = 3; error bars represent the standard deviation.

Journal: ACS Omega

Article Title: Integration of Magnetic Bead-Based Cell Selection into Complex Isolations

doi: 10.1021/acsomega.7b01427

Figure Lengend Snippet: Characterization of the release from FlowComp and CELLection beads. (A,B) Release of a fluorescently labeled anti-EpCAM antibody from (A) FlowComp and (B) CELLection beads. Beads were labeled with low, medium, and high levels of antibody and released for the specified time intervals. (A,B) Dots represent the average of three technical replicates with each technical replicate representing the average of 100 beads (total of 300 beads); error bars represent the standard deviation of the technical replicates. (C) Release of 22Rv1s from FlowComp and CELLection beads across time. (D) Capture efficiency of both FlowComp and CELLection beads when used to capture Du145, 22Rv1, and LNCaP cells. (E) Release efficiency of the three cell lines following bead-based capture. (F) Effective capture following the release of the cells. Gray bars represent the population of cells lost during the release process because of the inefficient release. In each plot, bars represent an average of n = 3; error bars represent the standard deviation.

Article Snippet: For experiments involving release, a similar experimental design was followed, except that once washed, the beads and bound cells were dropped into a release well containing either FlowComp Release Buffer (FlowComp Flexi Kit 11061D, Thermo Fisher) or CELLection release buffer (CELLection Biotin Binder Kit 11533D, Thermo Fisher) prepared according to the manufacturer’s instructions (release volume of 110 μL).

Techniques: Labeling, Standard Deviation

Cell viability following capture and release. (A) The viability of cells (LNCaP, 22Rv1) bound to nonreleaseable beads compared to untouched cells (underwent no magnetic bead isolation) following a 3-day culture (abbreviations: SM = Sera-Mag). (B) The viability of cells bound to (bound) and released from (released) releasable beads (CELLection, FlowComp) following a 3-day culture. Bars represent the average of three technical replicates; error bars represent the standard deviation.

Journal: ACS Omega

Article Title: Integration of Magnetic Bead-Based Cell Selection into Complex Isolations

doi: 10.1021/acsomega.7b01427

Figure Lengend Snippet: Cell viability following capture and release. (A) The viability of cells (LNCaP, 22Rv1) bound to nonreleaseable beads compared to untouched cells (underwent no magnetic bead isolation) following a 3-day culture (abbreviations: SM = Sera-Mag). (B) The viability of cells bound to (bound) and released from (released) releasable beads (CELLection, FlowComp) following a 3-day culture. Bars represent the average of three technical replicates; error bars represent the standard deviation.

Article Snippet: For experiments involving release, a similar experimental design was followed, except that once washed, the beads and bound cells were dropped into a release well containing either FlowComp Release Buffer (FlowComp Flexi Kit 11061D, Thermo Fisher) or CELLection release buffer (CELLection Biotin Binder Kit 11533D, Thermo Fisher) prepared according to the manufacturer’s instructions (release volume of 110 μL).

Techniques: Isolation, Standard Deviation

Characterization of nucleic acid extraction with cell isolation magnetic beads present. (A,B) Relative fold change in the mRNA transcript (HPRT) detected from LNCaPs. Isolations containing cell isolation beads were compared to no-bead controls for two methods of RNA extraction: (A) spin columns and (B) bead-based extraction. (C,D) Similarly, relative fold change in GAPDH from DNA extracted via (C) spins columns or (D) bead-based extraction. Bars represent the average of three technical replicates; error bars represent the standard deviation; * denotes p < 0.05 and *** denotes p < 0.001; --- indicates the cell only, no-bead control (abbreviations: CELL = CELLection, SM = Sera-Mag, FC = FlowComp).

Journal: ACS Omega

Article Title: Integration of Magnetic Bead-Based Cell Selection into Complex Isolations

doi: 10.1021/acsomega.7b01427

Figure Lengend Snippet: Characterization of nucleic acid extraction with cell isolation magnetic beads present. (A,B) Relative fold change in the mRNA transcript (HPRT) detected from LNCaPs. Isolations containing cell isolation beads were compared to no-bead controls for two methods of RNA extraction: (A) spin columns and (B) bead-based extraction. (C,D) Similarly, relative fold change in GAPDH from DNA extracted via (C) spins columns or (D) bead-based extraction. Bars represent the average of three technical replicates; error bars represent the standard deviation; * denotes p < 0.05 and *** denotes p < 0.001; --- indicates the cell only, no-bead control (abbreviations: CELL = CELLection, SM = Sera-Mag, FC = FlowComp).

Article Snippet: For experiments involving release, a similar experimental design was followed, except that once washed, the beads and bound cells were dropped into a release well containing either FlowComp Release Buffer (FlowComp Flexi Kit 11061D, Thermo Fisher) or CELLection release buffer (CELLection Biotin Binder Kit 11533D, Thermo Fisher) prepared according to the manufacturer’s instructions (release volume of 110 μL).

Techniques: Extraction, Cell Isolation, Magnetic Beads, RNA Extraction, Standard Deviation, Control